Implementation of Substance Use Treatment in Ambulatory Care

The Decision Support Tool empowers providers to estimate Medicare and Medicaid revenue across prominent integrated care services to finance these services more effectively in community mental health care, substance use treatment and primary care provider organizations. It includes a list of specific billing codes, service types, professional discipline coverage, documentation and time requirements.

Provides resources for practitioners who supervise peer workers.

Describes what SBIRT is, how SBIRT services are covered by Medicare, and what types of healthcare providers may provide SBIRT services under Medicare. These include physicians, physician assistants, nurse practitioners, clinical nurse specialists, clinical psychologists, and clinical social workers.

Describes strategies to help reduce the potential for misuse or diversion of medication for SUD treatment.

Provides information about when healthcare professionals are legally allowed to disclose some health information related to OUD without a patient's permission.

Provides examples of patient behaviors that may indicate prescription medication abuse or addiction and behaviors that may appear aberrant but are likely to be part of the normal process of stabilizing a patient's pain condition.

Emphasizes the importance of continuing a mother’s treatment for OUD throughout pregnancy. Includes information on OUD and pregnancy, OUD treatment, neonatal abstinence syndrome, treatment of prenatal opioid exposure, and considerations to address before hospital discharge.

Outlines steps for the consideration and use of extended release naltrexone as a form of MAT.

Highlights the findings of the NIDA Clinical Trials Network study that compared longer term versus short-term buprenorphine/naloxone treatment in an outpatient setting. Examines opioid use, treatment with buprenorphine, and further implications for young adults with opioid addiction.

Provides information about treatment with methadone and buprenorphine for pregnant women.